Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

CVRX


Fundamental

Company: CVRx Inc
Sector: Healthcare
Industry: Medical Devices
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -2.04
Insider Own: 43.78%
Shs Outstand: 26.31M
Perf Week: 19.23%
Market Cap: 233.40M
Forward P/E: -
EPS next Y: -1.78
Insider Trans: -0.27%
Shs Float: 14.79M
Perf Month: 82.90%
Enterprise Value: 208.19M
PEG: -
EPS next Q: -0.52
Inst Own: 31.65%
Short Float: 13.06%
Perf Quarter: 6.62%
Income: -53.31M
P/S: 4.12
EPS this Y: 1.54%
Inst Trans: 5.59%
Short Ratio: 5.43
Perf Half Y: 30.83%
Sales: 56.65M
P/B: 5.94
EPS next Y Percentage: 11.53%
ROA: -44.76%
Short Interest: 1.93M
Perf YTD: 24.94%
Book/sh: 1.49
P/C: 3.08
EPS next 5Y: 6.41%
ROE: -96.59%
52W High: 13.34 -33.50%
Perf Year: -27.17%
Cash/sh: 2.88
P/FCF: -
EPS past 3/5Y: -0.43% -22.44%
ROIC: -59.58%
52W Low: 4.30 106.32%
Perf 3Y: -10.22%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: 36.11% 56.40%
Gross Margin: 83.99%
Volatility W: 8.44%
Volatility M: 9.21%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 3.67
EPS Y/Y TTM: 24.27%
Oper. Margin: -90.49%
ATR (14): 0.63
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 6.72
Sales Y/Y TTM: 10.45%
Profit Margin: -94.10%
RSI (14): 65.75
Recom: 1.57
Dividend Gr. 3/5Y: - -
Current Ratio: 7.63
EPS Q/Q: -5.64%
SMA20: 12.84%
Beta: 1.21
Target Price: 11.17
Payout: -
Debt/Eq: 1.28
Sales Q/Q: 4.45%
SMA50: 25.87%
Rel Volume: 0.64
Prev Close: 8.50
Employees: 223
LT Debt/Eq: 1.28
Earnings: Feb 12 AMC
SMA200: 13.98%
Avg Volume: 356.13K
Price: 8.87
IPO: Jun 30, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: -4.88% 1.56%
Trades:
Volume: 28,221
Change: 4.36%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z
William Blair cuts CVRx stock rating on salesforce issues - Investing.com somewhat bearish
CVRX

Summary: CVRx Inc (NASDAQ:CVRX) was downgraded by William Blair from Outperform to Market Perform due to first-quarter sales falling short of expectations, leading to lower revenue guidance and internal salesforce issues impacting performance.

Full article
2024-05-01T17:35:02Z